Kunwar Shailubhai, Chief Scientific Officer at SYNERGY PHARMACEUTICALS, INC. (SGYP), bought 3,000 shares at $3.89 ($12K) on 2014-05-23, disclosed to the SEC on 2014-05-28.
Open-market purchase of $12k SGYP by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.